GROY vs. APYX
GROY (Gold Royalty Corp.) and APYX (Apyx Medical Corporation) are both stocks. GROY operates in Other Precious Metals & Mining (Basic Materials), while APYX operates in Medical Devices (Healthcare). Over the past 5 years, GROY returned -15.39%/yr vs -17.35%/yr for APYX. At a 0.12 correlation, their price movements are largely independent.
Performance
GROY vs. APYX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GROY achieves a -30.20% return, which is significantly lower than APYX's 16.57% return.
GROY
- 1D
- 0.71%
- 1M
- -10.19%
- YTD
- -30.20%
- 6M
- -32.86%
- 1Y
- 19.49%
- 3Y*
- 17.46%
- 5Y*
- -15.39%
- 10Y*
- —
APYX
- 1D
- 1.75%
- 1M
- -1.21%
- YTD
- 16.57%
- 6M
- 13.33%
- 1Y
- 104.00%
- 3Y*
- -17.63%
- 5Y*
- -17.35%
- 10Y*
- —
GROY vs. APYX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
GROY Gold Royalty Corp. | -30.20% | 233.88% | -17.69% | -36.27% | -51.98% | 9.33% |
APYX Apyx Medical Corporation | 16.57% | 121.52% | -39.69% | 11.97% | -81.75% | 19.37% |
Correlation
The correlation between GROY and APYX is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.09 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.13 |
Correlation (All Time) Calculated using the full available price history since Mar 9, 2021 | 0.12 |
Fundamentals
GROY:
-$0.01
APYX:
-$0.30
GROY:
28.95
APYX:
2.26
GROY:
$19.65M
APYX:
$55.83M
GROY:
$14.42M
APYX:
$21.29M
GROY:
$9.22M
APYX:
-$3.18M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GROY vs. APYX — Risk / Return Rank
GROY
APYX
GROY vs. APYX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Gold Royalty Corp. (GROY) and Apyx Medical Corporation (APYX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GROY | APYX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.84 | ||
| Sortino ratioReturn per unit of downside risk | -1.28 | ||
| Omega ratioGain probability vs. loss probability | 1.10 | 1.25 | -0.15 |
| Calmar ratioReturn relative to maximum drawdown | 0.41 | 2.86 | -2.45 |
| Martin ratioReturn relative to average drawdown | 0.96 | 6.86 | -5.91 |
Loading charts...
Drawdowns
GROY vs. APYX - Drawdown Comparison
The maximum GROY drawdown since its inception was -82.01%, smaller than the maximum APYX drawdown of -94.99%. Use the drawdown chart below to compare losses from any high point for GROY and APYX.
Loading charts...
Drawdown Indicators
| GROY | APYX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -82.01% | -94.99% | +12.98% |
Max Drawdown (1Y)Largest decline over 1 year | -48.18% | -36.59% | -11.59% |
Max Drawdown (3Y)Largest decline over 3 years | -48.18% | -88.52% | +40.34% |
Max Drawdown (5Y)Largest decline over 5 years | -79.99% | -94.99% | +15.00% |
Current DrawdownCurrent decline from peak | -56.63% | -76.55% | +19.92% |
Average DrawdownAverage peak-to-trough decline | -55.80% | -57.06% | +1.26% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 20.45% | 15.21% | +5.24% |
Volatility
GROY vs. APYX - Volatility Comparison
The current volatility for Gold Royalty Corp. (GROY) is 16.40%, while Apyx Medical Corporation (APYX) has a volatility of 22.15%. This indicates that GROY experiences smaller price fluctuations and is considered to be less risky than APYX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GROY | APYX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.40% | 22.15% | -5.75% |
Volatility (6M)Calculated over the trailing 6-month period | 38.13% | 55.41% | -17.28% |
Volatility (1Y)Calculated over the trailing 1-year period | 56.28% | 87.90% | -31.62% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 57.54% | 100.40% | -42.86% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 60.20% | 93.04% | -32.84% |
Dividends
GROY vs. APYX - Dividend Comparison
Neither GROY nor APYX has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
APYX Apyx Medical Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
GROY Gold Royalty Corp. | 0.00% | 0.00% | 0.00% | 1.36% | 1.72% |
Financials
GROY vs. APYX - Financials Comparison
This section allows you to compare key financial metrics between Gold Royalty Corp. and Apyx Medical Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GROY vs. APYX - Profitability Comparison
GROY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Gold Royalty Corp. reported a gross profit of 5.48M and revenue of 7.18M. Therefore, the gross margin over that period was 76.3%.
APYX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Apyx Medical Corporation reported a gross profit of 7.93M and revenue of 12.42M. Therefore, the gross margin over that period was 63.8%.
GROY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Gold Royalty Corp. reported an operating income of 2.64M and revenue of 7.18M, resulting in an operating margin of 36.7%.
APYX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Apyx Medical Corporation reported an operating income of -911.00K and revenue of 12.42M, resulting in an operating margin of -7.3%.
GROY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Gold Royalty Corp. reported a net income of 1.77M and revenue of 7.18M, resulting in a net margin of 24.7%.
APYX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Apyx Medical Corporation reported a net income of -2.11M and revenue of 12.42M, resulting in a net margin of -17.0%.
Frequently Asked Questions
GROY and APYX have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
APYX has higher volatility (22.15%) compared to GROY (16.40%). In terms of maximum drawdown, GROY dropped -82.01% vs APYX's -94.99%.
APYX currently has the higher Sharpe Ratio (1.19 vs 0.35), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for GROY and APYX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer